Murashko announced a sufficient number of medicines in warehouses in Russia

Warehouses in RUSSIA have a sufficient amount of medicines, HEALTH Minister Mikhail Murashko said in an interview with journalist Naila Asker-zade on the Rossiya 1 TV channel.

“There are a sufficient number of medicines in warehouses and medical organizations,” Murashko said.

According to him, for privileged categories of citizens today, stocks of medicines will last for more than 8-12 months in different categories.

How dependent is Russia on imported drugs. Infographics Business

After the imposition of Western sanctions, some foreign pharmaceutical companies suspended the supply of certain drugs to Russia, and also refused clinical trials and investments in the country. At the same time, Roszdravnadzor claimed that they were not afraid of a shortage of medicines.

At the end of March, Deputy Prime Minister Tatyana Golikova instructed the Ministry of Health to start searching for drugs that are not produced in Russia and friendly foreign countries in case of a shortage of foreign analogues.

So, earlier Kommersant reported about the shortage in Russia of drugs with levodopa, which are necessary for patients with Parkinson's disease. According to the publication, the Israeli company Teva stopped supplying Levodopa / Benserazit-Teva to Russia, and earlier another drug, Madopar from Hoffmann-La Roche, left the market, after which domestic drugs (Benziel) remained on the market ( from Canonpharma) and Levodopa + Benserazide (Izvarino Pharma), but they also disappeared from pharmacies. and after the imposition of sanctions, the situation worsened.

Read on RBC Pro Pro Without VMI or without bonuses:what companies should give up first of all Articles Pro What happens to international companies with Russian origin Articles ProDeceptive grandiosity: what killed the pioneer of express delivery from the 90s Articles Pro Gas for rubles:how this scheme will change the economies of Russia and the EUHow Chinese Brands Will Fill the Vacuum in the Russian Market6 Billion Pro Articles Turn East:what prevents CHINA from quickly entering the Russian market Articles

As RBC was told in the Ministry of Health, they, together with the Federal Antimonopoly Service, began re-registering prices for scarce drugs. For example, now the ministry has received documents for re-registration of the price of medicines "Benziel", "Levodopa + Benserazide" and "Sindopa" (produced in India), the ministry clarified.